We observed such trends in multiple clinical datasets (GSE66676, GSE33814, GSE37031) corresponding to NASH and/or NAFLD patients that showed PPARγ and HNF4α to be negatively correlated (Figure 6A). This evidence concerns the gene HNF4A and metabolic dysfunction-associated steatohepatitis.